HBL cells belong to the triple-WT molecular subtype of melanomas (NRAS, BRAF and NF1 WT) and they respond to stimulation with melanocortin agonists with strong increases in both cAMP and ERK1 and ERK2 activity [26]. Here, NRAS is linked to melanoma.